<clinical_study>
<study_id>
<org_name>
  HerlevH
</org_name>
<org_full_name>
  Herlev Hospital
</org_full_name>
<org_study_id>
  BS12-000733
</org_study_id>
<nct_id>
  NCT01597011
</nct_id>
</study_id>
<is_fda_regulated>
  No
</is_fda_regulated>
<brief_title>
<textblock>
  Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh Fixation
</textblock>
</brief_title>
<official_title>
<textblock>
  Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh Fixation
</textblock>
</official_title>
<study_sponsor>
<lead_sponsor>
<agency>
  Herlev Hospital
</agency>
</lead_sponsor>
</study_sponsor>
<resp_party>
<resp_party_type>
  Principal Investigator
</resp_party_type>
<investigator_full_name>
  Neel Maria Helvind
</investigator_full_name>
<investigator_title>
Principal Investigator 
</investigator_title>
<investigator_affiliation>
  Herlev Hospital
</investigator_affiliation>
</resp_party>
<oversight_info>
<regulatory_authority>
  Denmark: Danish Dataprotection Agency
</regulatory_authority>
<has_dmc>
  No
</has_dmc>
</oversight_info>
<brief_summary>
<textblock>
  In hernia repair a mesh is used to close the defect in the abdominal wall. This mesh is either secured with tissue penetrating devices (ex. staples,tacks or sutures) or fibrin glue (Tisseel/Tissucol) or left unfixated.
  The investigators believe, and previous studies indicate, that the use of fibrin glue greatly reduces the amount of postoperative complications (ex. chronic pain, impaired ejaculation in men or recurrence of the hernia)when compared with the use of tacks or staples.
  The aim of this study is to compare the recurrence rates and amount of postoperative complications in patients who have had inguinal hernia repair with fibrin glue and in patients who have had inguinal hernia repair with tacks, staples or sutures.
</textblock>
</brief_summary>
<detailed_descr>
<textblock>
  The study will use prospectively collected data from the Danish Hernia Database to find the patients. The patients will be contacted using a questionnaire.
</textblock>
</detailed_descr>
<status_block>
<status>
  Not yet recruiting
</status>
<date>
  2012-05
</date>
</status_block>
<start_date>
<date>
  2012-07
</date>
</start_date>
<last_follow_up_date
 type="Anticipated"
>
<date>
  2013-03
</date>
</last_follow_up_date>
<primary_compl_date
 type="Anticipated"
>
<date>
  2012-12
</date>
</primary_compl_date>
<phase_block>
<phase>
</phase>
</phase_block>
<study_type>
  Observational
</study_type>
<design>
  Case-Control
</design>
<design>
  Other
</design>
<biospec_retention>
  None Retained
</biospec_retention>
<biospec_descr>
<textblock>
</textblock>
</biospec_descr>
<number_of_groups>
  2
</number_of_groups>
<primary_outcome>
<measure>
  Chronic pain
</measure>
<time_frame>
  within period from one year after procedure until follow-up
</time_frame>
<description>
<textblock>
  Reported pain (questionnaire) from one year after procedure
</textblock>
</description>
<safety_issue>
  No
</safety_issue>
</primary_outcome>
<secondary_outcome>
<measure>
  Recurrence
</measure>
<time_frame>
  within period from procedure to follow-up
</time_frame>
<description>
<textblock>
  Reherniation at repaired site. Defined as a clinically observable hernia or reoperation prior to follow-up
</textblock>
</description>
<safety_issue>
  No
</safety_issue>
</secondary_outcome>
<secondary_outcome>
<measure>
  dysejaculation
</measure>
<time_frame>
  Debut within period from procedure to follow-up
</time_frame>
<description>
<textblock>
  Reported ejaculatory dysfunction in male patients
</textblock>
</description>
<safety_issue>
  No
</safety_issue>
</secondary_outcome>
<enrollment
 type="Anticipated"
>
  2000
</enrollment>
<condition>
  Hernia, Inguinal
</condition>
<condition>
  Recurrence
</condition>
<condition>
  Chronic Pain
</condition>
<arm_group>
<arm_group_label>
  Tisseel group
</arm_group_label>
<description>
<textblock>
  Patients who have undergone inguinal hernia repair with fibrin sealant/fibrin glue/Tisseel for mesh fixation
</textblock>
</description>
</arm_group>
<arm_group>
<arm_group_label>
  Tissue-penetrating fixation group
</arm_group_label>
<description>
<textblock>
  Patients who have undergone inguinal hernia repair with the use of tacks, staples or sutures for mesh fixation
</textblock>
</description>
</arm_group>
<intervention>
<intervent_type>
  Procedure/Surgery
</intervent_type>
<primary_name>
  Tisseel
</primary_name>
<description>
<textblock>
  Use of Tisseel for mesh fixation in inguinal hernia repair,
</textblock>
</description>
<arm_group_label>
  Tisseel group
</arm_group_label>
<other_name>
  Tisseel
</other_name>
<other_name>
  Fibrin glue
</other_name>
<other_name>
  Fibrin sealant
</other_name>
</intervention>
<intervention>
<intervent_type>
  Procedure/Surgery
</intervent_type>
<primary_name>
  Tissue-penetrating mesh-fixation
</primary_name>
<description>
<textblock>
  Use of tacks, staples or sutures for mesh fixation in inguinal hernia repair
</textblock>
</description>
<arm_group_label>
  Tissue-penetrating fixation group
</arm_group_label>
<other_name>
  Protacks
</other_name>
<other_name>
  Hernia stapler
</other_name>
</intervention>
<eligibility>
<criteria>
<textblock>
  Inclusion Criteria:
  inguinal hernia repair from June 1996-June 2011
  Exclusion Criteria:
  Patients lost to follow-up
</textblock>
</criteria>
<healthy_volunteers>
  No
</healthy_volunteers>
<gender>
  Both
</gender>
<minimum_age>
  18 Years
</minimum_age>
<maximum_age>
</maximum_age>
<study_pop>
<textblock>
  Patients will be enrolled based on their registration in the Danish Hernia Database. All patients in the database who have undergone inguinal hernia repair from June 1996 to June 2011 will be included
</textblock>
</study_pop>
<sampling_method>
  Non-Probability Sample
</sampling_method>
</eligibility>
<investigator>
<role>
  Principal Investigator
</role>
<name>
  Neel M Helvind, Researcher
</name>
<affiliation>
<agency>
  Herlev Hospital
</agency>
</affiliation>
</investigator>
<investigator>
<role>
  Study Chair
</role>
<name>
  Jacob Rosenberg, professor
</name>
<affiliation>
<agency>
  Herlev Hospital
</agency>
</affiliation>
</investigator>
<contact>
<name>
  Neel M Helvind, Researcher
</name>
<phone>
  +45 27286810
</phone>
<phone_ext>
</phone_ext>
<email>
  neelhe@stud.ku.dk
</email>
</contact>
<contact>
<name>
  Jacob Rosenberg, Professor
</name>
<phone>
  +45 38683600
</phone>
<phone_ext>
</phone_ext>
<email>
  jacob.rosenberg@regionh.dk
</email>
</contact>
<location>
<facility>
<name>
  Herlev Hospital
</name>
<address>
<city>
  Herlev
</city>
<state>
</state>
<zip>
  2730
</zip>
<country>
  Denmark
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Neel M Helvind, Researcher
</name>
<phone>
  +45 27286810
</phone>
<phone_ext>
</phone_ext>
<email>
  neelhe@stud.ku.dk
</email>
</contact>
<contact>
<name>
  Jacob Rosenberg, Professor
</name>
<phone>
  +45 38683600
</phone>
<phone_ext>
</phone_ext>
<email>
  jacob.rosenberg@regionh.dk
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Neel Helvind, Researcher
</name>
</contact>
<contact>
<role>
  Sub-Investigator
</role>
<name>
  Jacob Rosenberg, Professor
</name>
</contact>
<contact>
<role>
  Sub-Investigator
</role>
<name>
  Thue Bisgaard, Researcher
</name>
</contact>
</location>
<keyword>
  Hernia, Inguinal
</keyword>
<keyword>
  Hernia repair
</keyword>
<keyword>
  Fibrin Tissue Adhesive
</keyword>
<keyword>
  Tisseel
</keyword>
<keyword>
  Tissucol
</keyword>
<keyword>
  Recurrence
</keyword>
<keyword>
  Chronic Pain
</keyword>
<keyword>
  Dysejaculation
</keyword>
<initial_release_date>
  2012-05-09
</initial_release_date>
<last_release_date>
2012-05-15 
</last_release_date>
<init_disposition_release_date>
</init_disposition_release_date>
<init_results_release_date>
</init_results_release_date>
</clinical_study>
